Welcome to our dedicated page for AMPERCAP ACQUISITION CO SEC filings (Ticker: APMCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPERCAP ACQUISITION CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPERCAP ACQUISITION CO's regulatory disclosures and financial reporting.
AmperCap Acquisition Company reports that its IPO underwriters partially exercised their over-allotment option, buying 1,837,500 additional units at $10.00 per unit for gross proceeds of $18,375,000. This follows the earlier sale of 12,500,000 IPO units at $10.00 each for $125,000,000 and 512,500 private placement units for $5,125,000.
The sponsors and EarlyBirdCapital also bought 55,125 additional private placement units at $10.00 each, adding $551,250. In total, approximately $144,808,750 from the IPO, over-allotment, and private placements has been deposited into a U.S.-based trust account. Because the over-allotment was not fully exercised, the sponsor forfeited 12,500 founder shares.
AmperCap Acquisition Co’s sponsor, AmperSPAC LLC, reported updated ownership activity in its Form 4/A. The sponsor purchased 247,500 Issuer private placement units at $10 per unit, each unit including one ordinary share and one right to receive one-tenth of an ordinary share upon the initial business combination.
The amendment also records a prior private transfer of 1,147,500 founder shares from the sponsor to third-party investors for about $5,987, or roughly $0.005 per share. After these transactions, the sponsor holds 3,644,167 ordinary shares and 247,500 rights, with managing members Harish Dadoo Gonzalez and Alberto Gutierrez Pier potentially deemed beneficial owners through the sponsor subject to their pecuniary interests.
AmperCap Acquisition Co’s sponsor, AmperSPAC LLC, increased its position through open-market activity tied to the SPAC’s over-allotment option. On June 10, 2026, the sponsor purchased 34,912 ordinary shares at $10.00 per share and 34,912 rights to receive ordinary shares.
Footnotes state the sponsor forfeited 12,500 ordinary shares when underwriters partially exercised their over-allotment option, leaving it with 3,879,167 ordinary shares, and that additional private placement units raised holdings to 3,914,079 ordinary shares as of June 12, 2026. The 34,912 rights may convert into 3,491 ordinary shares upon completion of the initial business combination. Harish Dadoo Gonzalez and Alberto Gutierrez Pier, as managing members of the sponsor, may be deemed beneficial owners but disclaim ownership beyond their pecuniary interest.
AmperSPAC LLC and its principals report a significant stake in AmperCap Acquisition Company, a blank check company. The group discloses beneficial ownership of 3,914,079 ordinary shares, representing 19.61% of the 19,958,575 shares outstanding as of June 11, 2026.
The position consists of 3,631,667 founder shares and 282,412 ordinary shares included in private placement units, purchased for an aggregate $25,000 and $5,676,250, respectively. Additional rights attached to these units could convert into 28,241 more shares upon completion of a business combination.
Through a series of agreements, the sponsor and insiders have committed to vote their founder and related shares in favor of any proposed business combination, not redeem these shares, and observe lock-up and transfer restrictions, generally lasting until after a successful business combination or liquidation if no deal is completed within 21 months of the IPO.
AmperCap Acquisition Company ownership disclosure: Sculptor Capital reports beneficial ownership of 1,064,442 units, equal to 6.11% of the class. The percentage is calculated using 17,418,297 units outstanding as set forth in the issuer's Form 424B4 filed June 3, 2026. The units are held in accounts managed by Sculptor and related entities and are presented on behalf of multiple affiliated business units.
AmperCap Acquisition Co’s sponsor entity, AmperSPAC LLC, purchased 247,500 private placement units at $10 per unit. Each unit consists of one ordinary share and one right to receive one-tenth of an ordinary share upon the company’s initial business combination.
This results in 247,500 ordinary shares and 247,500 rights, which are convertible into 24,750 ordinary shares. The units are held of record by AmperSPAC LLC. Co-CEOs and directors Harish Dadoo Gonzalez and Alberto Gutierrez Pier are managing members of the sponsor and may be deemed beneficial owners to the extent of their pecuniary interest.
AmperCap Acquisition Company completed its initial public offering of 12,500,000 units at $10.00 per unit, raising gross proceeds of $125,000,000. Each unit includes one ordinary share and one right to receive one-tenth of an ordinary share upon completion of an initial business combination.
The company also sold 512,500 private placement units at $10.00 per unit to its sponsor, EarlyBirdCapital and certain investors. A total of $126,250,000 from the IPO and private placement proceeds was deposited into a U.S.-based trust account, with the balance allocated to working capital. AmperCap is a blank check company targeting middle-market businesses with ties to the United States and Mexico and has 21 months from the IPO closing to complete a business combination, subject to its governing documents.
AmperCap Acquisition Company is offering 12,500,000 units in an initial public offering totaling $125,000,000. Each unit is priced at $10.00 and contains one ordinary share and one Share Right equal to one‑tenth of a share upon a successful business combination. The underwriting includes a 45‑day option for 1,875,000 additional units. Approximately $126,250,000 (or $145,187,500 if the over‑allotment is fully exercised) of proceeds will be placed in a U.S. trust account; roughly $800,000 of working capital is expected to remain available outside the trust. The sponsor acquired 4,791,667 founder shares for $25,000, and sponsor, certain directors and underwriter affiliates will purchase an aggregate of 512,500 private placement units at $10.00 per unit. The company has a 21‑month window to complete a business combination and may redeem public shares for pro rata trust account amounts if no combination is completed within that period.
AmperCap Acquisition Company, a Cayman Islands blank check company, is seeking to raise $125,000,000 in its initial public offering of 12,500,000 units at $10.00 each. Each unit includes one ordinary share and one right to receive one tenth of an ordinary share after a future business combination.
The SPAC plans to focus mainly on middle‑market businesses tied to the United States and Mexico or serving the U.S. Hispanic market. At least $126,250,000, or $10.10 per public share, will be placed in a U.S. trust account to fund a business combination or redemptions. AmperCap has up to 21 months after the IPO closing to complete a deal or return trust funds to public shareholders.
The sponsor bought 4,791,667 founder shares for $25,000 (about $0.005 per share) and, together with third‑party investors and the underwriter’s affiliate, will acquire 512,500 private placement units at $10.00 per unit. Because insiders paid a nominal price for founder shares, public investors face immediate and substantial dilution, and the sponsor’s low-cost stake and various fee and reimbursement arrangements create potential conflicts of interest when evaluating any future business combination.